The time is now for this oral T2D therapy

Indications and Usage



RYBELSUS® (semaglutide) tablets 7 mg or 14 mg is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.



Limitations of Use

• RYBELSUS® is not recommended as a first-line therapy for patients who have inadequate glycemic control on diet and exercise because of the uncertain relevance of rodent C-cell tumor findings to humans


• RYBELSUS® has not been studied in patients with a history of pancreatitis. Consider other antidiabetic therapies in patients with a history of pancreatitis


• RYBELSUS® is not indicated for use in patients with type 1 diabetes

Please scroll below for Important Safety Information or click here for Prescribing Information, including Boxed Warning.